Barclays Lowers RXO (NYSE:RXO) Price Target to $30.00

RXO (NYSE:RXO) had its price objective decreased by Barclays from $32.00 to $30.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price target indicates a potential upside of 18.69% from the company’s current price.

RXO has been the topic of a number of other reports. Susquehanna reduced their price objective on shares of RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a report on Tuesday, November 12th. The Goldman Sachs Group restated a “neutral” rating and issued a $29.00 price target on shares of RXO in a research note on Monday, November 18th. Citigroup downgraded RXO from a “buy” rating to a “neutral” rating and set a $33.00 price target for the company. in a report on Tuesday, November 12th. Benchmark reiterated a “hold” rating on shares of RXO in a report on Wednesday. Finally, Wells Fargo & Company cut their target price on RXO from $31.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 7th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $26.77.

RXO Stock Down 1.2 %

NYSE RXO traded down $0.30 during trading hours on Friday, hitting $25.28. 395,039 shares of the company were exchanged, compared to its average volume of 866,767. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. The firm has a market cap of $4.06 billion, a price-to-earnings ratio of -12.79, a PEG ratio of 3.17 and a beta of 1.52. The company has a 50 day moving average of $26.82 and a two-hundred day moving average of $27.79. RXO has a 52-week low of $18.75 and a 52-week high of $32.82.

RXO (NYSE:RXO) last released its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $956.19 million. During the same period in the prior year, the firm earned $0.05 earnings per share. The business’s quarterly revenue was up 6.6% compared to the same quarter last year. Equities research analysts anticipate that RXO will post 0.11 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Wilmington Savings Fund Society FSB purchased a new stake in shares of RXO in the third quarter valued at about $28,000. Nomura Asset Management Co. Ltd. raised its stake in RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after acquiring an additional 570 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its stake in RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock valued at $43,000 after acquiring an additional 1,445 shares during the last quarter. GAMMA Investing LLC lifted its position in RXO by 40.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after acquiring an additional 510 shares during the period. Finally, Canada Pension Plan Investment Board purchased a new position in shares of RXO in the 2nd quarter valued at approximately $112,000. 92.73% of the stock is owned by hedge funds and other institutional investors.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.